Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Novartis' First-in-Class Biologic Psoriasis Treatment Approved in China

publication date: Apr 3, 2019

Novartis announced that China's NMPA approved Cosentyx® (secukinumab), a first-in-class biologic interleukin-17A (IL-17A) inhibitor for moderate-to-severe plaque psoriasis. Cosentyx, which is approved for adult patients who are candidates for systemic therapy or phototherapy, is the ninth new Novartis drug approved in China over the last two years. The company expects to bring ten more novel drugs to the China market during the next few years, including its Kymriah CAR-T treatment for cancer. Novartis expects China will become its third largest market. More details....

Stock Symbol: (NYSE: NVS)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here